Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 462.40M | 508.00M | 448.83M | 374.61M | 373.82M |
Gross Profit | 349.41M | 386.62M | 348.35M | 306.06M | 297.46M |
EBITDA | -168.34M | -263.91M | 359.82M | 358.40M | 393.93M |
Net Income | -299.76M | -347.69M | 125.63M | 611.84M | 314.36M |
Balance Sheet | |||||
Total Assets | 6.05B | 7.63B | 8.51B | 7.06B | 5.85B |
Cash, Cash Equivalents and Short-Term Investments | 51.25M | 72.03M | 87.99M | 62.70M | 144.11M |
Total Debt | 3.01B | 3.92B | 3.68B | 2.94B | 2.79B |
Total Liabilities | 3.47B | 4.54B | 4.77B | 3.54B | 3.31B |
Stockholders Equity | 1.56B | 1.99B | 2.46B | 2.39B | 1.64B |
Cash Flow | |||||
Free Cash Flow | 85.76M | 104.67M | 223.56M | 124.48M | 188.53M |
Operating Cash Flow | 86.64M | 104.77M | 224.18M | 124.97M | 188.77M |
Investing Cash Flow | 540.08M | 194.27M | -1.36B | -914.83M | -628.53M |
Financing Cash Flow | -650.57M | -318.50M | 1.18B | 711.19M | 397.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | C$2.28B | 3.57 | 22.26% | 3.77% | 5.77% | 108.23% | |
75 Outperform | C$947.95M | 8.55 | 5.83% | 4.15% | 3.85% | -31.81% | |
71 Outperform | C$530.42M | 5.98 | 9.03% | 3.58% | -0.29% | ― | |
70 Outperform | C$5.16B | 85.26 | 5.86% | 3.52% | 20.03% | -63.03% | |
70 Outperform | C$1.86B | ― | -7.00% | 2.93% | 2.52% | -573.45% | |
59 Neutral | C$1.27B | -2.56 | -8.19% | 4.91% | 10.84% | -18.98% | |
54 Neutral | C$1.21B | ― | -14.74% | 7.44% | -11.49% | 15.58% |
Northwest Healthcare Properties REIT announced it will release its financial results for the second quarter of 2025 on August 12, after market close, with a conference call scheduled for the following day. This announcement is part of Northwest’s ongoing communication strategy to keep stakeholders informed about its financial performance, which could impact investor confidence and market positioning.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT has announced the appointment of Zachary Vaughan as its new Chief Executive Officer, effective July 2, 2025, following the retirement of Craig Mitchell. Vaughan brings extensive international real estate experience and a proven track record in strategic roles, which is expected to guide Northwest into a new chapter of growth and value creation for investors.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT announced a distribution of $0.03 per unit for June 2025, payable on July 15, 2025, with an annualized distribution of $0.36 per unit. The REIT offers a distribution reinvestment plan allowing unitholders to reinvest cash distributions into Trust Units and receive bonus units, enhancing shareholder value and potentially increasing investment returns.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT announced significant changes following its 2025 annual meeting, including the election of trustees, appointment of Robert Julien as the new Chair of the Board, and the formation of an Investment Committee chaired by Graham Garner. These strategic moves aim to enhance governance and refocus leadership, building on the foundation laid by outgoing Chair Dale Klein. The changes are expected to strengthen Northwest’s position in the healthcare real estate market, providing a robust platform for long-term success.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT has provided an update regarding Healthscope, its second-largest tenant, whose parent entities have entered receivership. Despite this, Healthscope’s operational business remains unaffected, with management continuing to focus on patient care. McGrathNicol Restructuring has been appointed to facilitate an orderly sale of Healthscope, supported by a $100 million funding package from the Commonwealth Bank of Australia. Northwest intends to collaborate with McGrathNicol and potential bidders during the sale process, with all current rent obligations from Healthscope being met.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT has declared a distribution of $0.03 per unit for May 2025, equating to $0.36 per unit on an annualized basis, payable on June 13, 2025. The announcement reflects the company’s commitment to providing consistent returns to its unitholders, with the added benefit of a distribution reinvestment plan that offers bonus Trust Units. This move underscores Northwest’s stable financial performance and its strategic positioning in the healthcare real estate sector, potentially enhancing stakeholder value.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT reported its first quarter 2025 results, highlighting significant progress in financial and operational metrics. The company successfully executed its capital recycling strategy with over $260 million in non-core asset sales, reduced its payout ratio, and improved its balance sheet through debt repayment and refinancing. Despite a decrease in revenue due to asset dispositions, the REIT achieved a 4.5% increase in same property net operating income and maintained a strong global portfolio occupancy rate of 96.5%. The REIT’s strategic actions have positioned it well for long-term value creation for its unitholders.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.